In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When-Workshop Summary Report.


Journal

The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209

Informations de publication

Date de publication:
19 05 2020
Historique:
received: 20 02 2020
accepted: 08 04 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 10 6 2021
Statut: epublish

Résumé

The pharmaceutical industry and regulatory agencies rely on dissolution similarity testing to make critical product performance decisions as part of drug product life cycle management. Accordingly, the application of mathematical approaches to evaluate dissolution profile similarity is described in regulatory guidance. However, the requirements (e.g., which time points, number of time points, %CV) to apply the widely known similarity factor f

Identifiants

pubmed: 32430592
doi: 10.1208/s12248-020-00458-9
pii: 10.1208/s12248-020-00458-9
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

74

Subventions

Organisme : FDA HHS
ID : U01 FD005946
Pays : United States

Auteurs

Sandra Suarez-Sharp (S)

Division of Biopharmaceutics, Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
Regulatory affairs, Simulations Plus Inc, 42505 10th Street West, Lancaster, California, 93534, USA.

Andreas Abend (A)

Pharmaceutical Sciences, Merck & Co Inc, 770 Sumneytown Pike, West Point, Pennsylvania, 19486, USA.

Thomas Hoffelder (T)

Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Straße 173, 55216, Ingelheim am Rhein, Germany.

David Leblond (D)

CMC Statistical Studies, 3091 Midlane Drive, Wadsworth, Illinois, 60083, USA.

Poonam Delvadia (P)

Division of Biopharmaceutics, Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, USA.

Elisabeth Kovacs (E)

Analytical R&D/Biopharmaceutics/Product Development and Life Cycle Management, EK Consulting 6 Reditt Crt, Richmond Hill, Ontario, L4C 7S4, Canada.

Dorys Argelia Diaz (DA)

Global Product Development, Pfizer Inc, Eastern Point Road, Groton, Connecticut, 06340, USA. dorys.argelia.diaz@pfizer.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH